Statement
26 Aug 2026
76th WHO Regional Committee for Africa: Special update on the ongoing Ebola virus disease outbreak caused by Bundibugyo Virus
On 26 August, IFPMA delivered a statement on the special update on the ongoing Ebola virus disease outbreak caused by Bundibugyo Virus at the 76th session off the WHO Regional Committee for Africa in Addis Ababa. Marking the 100th day after the Bundibugyo outbreak was declared, the global pharmaceutical industry underscores its commitment and track...
Read more
Statement
22 Jun 2026
2026 UN High-Level Meeting on HIV/AIDS
On 22 June 2026, IFPMA delivered a statement at the UN High-Level Meeting on HIV/AIDS in New York. Excellencies, distinguished delegates, I am pleased to speak on behalf of the IFPMA, representing the innovative pharmaceutical industry. As Member States gather at this High-Level Meeting to renew global commitments on HIV/AIDS, IFPMA welcomes the Political Declaration’s...
Read more
Statement
14 May 2026
Multi-Stakeholder Hearing for the 2026 UN High-Level Meeting on HIV/AIDS
On 14 May 2026 in New York City, IFPMA delivered a statement at the Multi-Stakeholder Hearing ahead of the UN High-Level Meeting on HIV/AIDS. The 2026 High-Level Meeting comes at a sensitive but important moment for the global HIV response. Meaningful progress has been made, but it remains fragile, uneven, and vulnerable to reversal if...
Read more
